BANK OF AMERICA CORP /DE/ - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 58 filers reported holding OVID THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$152,433
-11.3%
39,696
-24.3%
0.00%
Q2 2023$171,908
+408.2%
52,411
+299.7%
0.00%
Q1 2023$33,829
+429.2%
13,112
+281.5%
0.00%
Q4 2022$6,393
-70.9%
3,437
-70.8%
0.00%
Q3 2022$22,000
-37.1%
11,751
-27.9%
0.00%
Q2 2022$35,000
-73.3%
16,307
-60.8%
0.00%
Q1 2022$131,000
+2083.3%
41,598
+2314.3%
0.00%
Q4 2021$6,000
-94.7%
1,723
-94.9%
0.00%
Q3 2021$114,000
-57.8%
33,672
-51.3%
0.00%
Q2 2021$270,000
+200.0%
69,102
+208.2%
0.00%
Q1 2021$90,000
+150.0%
22,424
+45.6%
0.00%
Q4 2020$36,000
-71.9%
15,399
-31.3%
0.00%
Q3 2020$128,000
-16.9%
22,411
+7.3%
0.00%
Q2 2020$154,000
+6.9%
20,887
-56.7%
0.00%
Q1 2020$144,000
+1340.0%
48,190
+1502.6%
0.00%
Q3 2019$10,000
-41.2%
3,007
-67.3%
0.00%
Q2 2019$17,000
-66.7%
9,197
-68.1%
0.00%
Q1 2019$51,000
-15.0%
28,834
+16.1%
0.00%
Q4 2018$60,000
+150.0%
24,845
+475.1%
0.00%
Q3 2018$24,000
+4.3%
4,320
+44.5%
0.00%
Q2 2018$23,000
+283.3%
2,989
+225.2%
0.00%
Q1 2018$6,0000.0%919
+48.2%
0.00%
Q4 2017$6,000
+200.0%
620
+161.6%
0.00%
Q3 2017$2,0002370.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,006,185$12,860,0005.90%
GLOBEFLEX CAPITAL L P 2,794,834$8,972,0000.92%
BVF INC/IL 6,631,051$21,286,0000.77%
EcoR1 Capital, LLC 6,082,200$19,524,0000.62%
CHI Advisors LLC 400,000$1,284,0000.43%
Ikarian Capital, LLC 705,082$2,264,0000.34%
Artal Group S.A. 2,500,000$8,025,0000.22%
DCF Advisers, LLC 141,701$455,0000.18%
PLATINUM INVESTMENT MANAGEMENT LTD 766,901$2,462,0000.07%
ACADIAN ASSET MANAGEMENT LLC 2,040,084$6,543,0000.02%
View complete list of OVID THERAPEUTICS INC shareholders